Esophagogastric adenocarcinoma
Clinical trials for Esophagogastric adenocarcinoma explained in plain language.
Never miss a new study
Get alerted when new Esophagogastric adenocarcinoma trials appear
Sign up with your email to follow new studies for Esophagogastric adenocarcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Triple therapy aims to boost Cancer-Free survival after surgery for HER2-Positive stomach cancer
Disease control CompletedThis phase II trial tests whether adding pembrolizumab (Keytruda) and trastuzumab (Ontruzant) to standard FLOT chemotherapy, given before and after surgery, can improve outcomes for people with HER2-positive esophagogastric adenocarcinoma. Participants receive the drug combinatio…
Matched conditions: ESOPHAGOGASTRIC ADENOCARCINOMA
Phase 2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New drug shows promise for Tough-to-Treat stomach cancer
Disease control CompletedThis study tested a drug called sacituzumab-govitecan in 58 people with advanced stomach cancer that had spread to other parts of the body. The drug targets a protein on cancer cells to deliver chemotherapy directly. The goal was to see if the drug could shrink tumors or slow the…
Matched conditions: ESOPHAGOGASTRIC ADENOCARCINOMA
Phase 1/2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC